(HealthDay News) — Nasal glucagon can effectively and efficiently manage moderate or severe hypoglycemic episodes (HEs) in real-world settings in adult patients with type 1 diabetes, according to a ...
Eli Lilly this week announced it has submitted applications to US and European regulatory agencies for nasal glucagon, which, if approved, could shave minutes and stress from the current method for ...
TORONTO, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Eli Lilly Canada is pleased to announce the approval and availability of a new rescue treatment for severe hypoglycemia, demonstrating Lilly’s commitment to ...
STOCKHOLM — New data on a needle-free nasal delivery system for glucagon for use in severe hypoglycemia presented at the European Association for the Study of Diabetes (EASD) 2015 Meeting here today ...
There’s some new guidance on treating hypoglycemia, or low blood sugar, in long-term care communities. It’s specifically geared for healthcare workers, though anyone who is a caregiver for someone ...
(RTTNews) - The U.S. Food and Drug Administration approved the first generic drug to treat severe hypoglycaemia or dangerously low blood sugar levels, which could occur in patients with diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback